Superoxide Is Involved in the Central Nervous System Activation and Sympathoexcitation of Myocardial Infarction–Induced Heart Failure
- 20 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 94 (3) , 402-409
- https://doi.org/10.1161/01.res.0000112964.40701.93
Abstract
Increased angiotensin II signaling in the brain has been shown to play a critical role in the excessive sympathoexcitation and development of heart failure (HF) after myocardial infarction (MI). We have recently demonstrated that reactive oxygen species mediate the actions of angiotensin II in the brain. In this study, we tested the hypothesis that increased redox signaling in central cardiovascular control regions is a key mechanism in the neurocardiovascular dysregulation that follows MI. Ligation of the left coronary artery induced a large MI and subsequent HF in adult C57BL/6 mice, as demonstrated by cardiac hypertrophy, hydrothorax, and ascites. Immunohistochemical analysis of Fos, a marker of neuronal activation, revealed a significant increase in the number of Fos-positive neurons in the paraventricular nucleus and supraoptic nucleus at 2 and 4 weeks after MI compared with sham mice. Intracerebroventricular injection of an adenoviral vector encoding superoxide dismutase (Ad-Cu/ZnSOD) caused a significant decrease in the number of Fos-positive neurons in the paraventricular nucleus and supraoptic nucleus at 2 weeks after MI compared with mice receiving either saline or a control vector (Ad-LacZ). There was also a diminished role of sympathetic drive in post-MI mice treated centrally with Ad-Cu/ZnSOD, as demonstrated by significantly attenuated falls in heart rate and mean arterial pressure to the ganglionic blocker hexamethonium and decreased urinary norepinephrine levels in these mice compared with Ad-LacZ–treated MI mice. These results suggest that superoxide plays a key role in the central activation and sympathetic hyperactivity after MI in mice and that oxygen radicals in the brain may be important new targets for therapeutic treatment of heart failure.Keywords
This publication has 29 references indexed in Scilit:
- Oxidative Stress Mediates Tumor Necrosis Factor-α–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac MyocytesCirculation, 2003
- Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanismsActa Physiologica Scandinavica, 2002
- EPIDEMIOLOGY OF HEARY FAILURECardiology Clinics, 2001
- Hormones and Hemodynamics in Heart FailureNew England Journal of Medicine, 1999
- The brain is a possible target for an angiotensinconverting enzyme inhibitor in the treatment of chronic heart failureJournal of Cardiac Failure, 1998
- ACTIONS OF ANGIOTENSIN IN THE SUBFORNICAL ORGAN AND AREA POSTREMA: IMPLICATIONS FOR LONG TERM CONTROL OF AUTONOMIC OUTPUTClinical and Experimental Pharmacology and Physiology, 1997
- Identification of osmoresponsive neurons in the forebrain of the rat: a Fos study at the ultrastructural levelBrain Research, 1996
- Effects of deoxycorticosterone acetate (DOCA) and aldosterone on Sar1-angiotensin II binding and angiotensin-converting enzyme binding sites in brainCellular and Molecular Neurobiology, 1993
- Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentrationAmerican Heart Journal, 1987
- Hypothalamic Integration: Organization of the Paraventricular and Supraoptic NucleiAnnual Review of Neuroscience, 1983